Viome CancerDetect
—Oral and Throat

A chance to make a difference when it matters most.

Oral and Throat Cancer Detection Test built on Viome platform was designated Breakthrough Device by FDA

Early detection saves lives

Detecting cancer early is important. The earlier it is
detected, the higher the chance of survival.


survival rate
with late detection

The overall 5-year survival rate for people with late stage oral cancer is 40%2


survival rate
with early detection

If diagnosed at an early stage, the overall 5-year survival rate is 84%3


of patients get
diagnosed early

Unfortunately, with today’s practices, only 28% of patients are diagnosed at an early stage2

"Having practiced oral medicine, I saw how destructive cancers were to patients who were often diagnosed too late. Even if I could wind back the clock, there were no reliable solutions to capture these patients in early stages when it mattered the most. Now we have a chance to make a difference: with Viome's CancerDetect - Oral & Throat, we can detect oral and throat cancers at very early stages and decrease the chance of future suffering as much as possible. As a former dentist, this changes everything and is a tremendous source of hope for the future of medicine."

[CD Landing] Gloria YU Picture

Gloria Yu


Getting Tested

CancerDetect is recommended for individuals 50 years and older or anyone who has a history of smoking such as cigarettes, vaping, or chewing tobacco.

Eligible customers can order a kit delivered to your door. Collect your saliva sample and use a prepaid shipping label to mail to our CLIA-certified laboratory.

Expect your result within 4 weeks: after a healthcare provider from our partner, PWNHealth, reviews your analysis, a printable report (PDF) will be available on If molecular features are detected, the same provider will call you to guide you through your report.


Are you eligible?

Complete the eligibility form and follow simple steps to order your test. A healthcare provider will review your test request in 48 hours.

Early Detection Puts Your

Health In Your Hands

[Common Icon] Candle


Easy Saliva Test
takes 10 minutes

[Common Icon] House


Test at home or
on your schedule

[Common Icon] Shield


High sensitivity & specificity
results you can trust

[Common Icon] Medal

Best in class

Objective & reproducible
for peace of mind


woman-holding-iphone mobile@3x

More Questions?

Important Safety Information

CancerDetect - Oral & Throat is a lab-developed test (LDT) performed in our Clinical Laboratory located in Bothell, Washington. The Laboratory is designed to meet all federal and state regulatory, quality and CLIA criteria. The test is intended for use as a diagnostic aid in the detection of molecular features associated with OSCC and/or OPSCC. The test is ≥ 90% OSCC sensitive, ≥ 90% OPSCC sensitive and has a specificity of ≥ 95%.1

The CancerDetect - Oral & Throat test is recommended for use in adults with an elevated risk for oral & throat cancer such as those aged 50 or older or individuals who have a history of smoking, chewing tobacco, vaping, or using other forms of tobacco, heavy alcohol drinkers, or individuals with a high risk of HPV. The CancerDetect - Oral & Throat test does not detect all cancers and should be used in addition to routine cancer tests recommended by a healthcare provider. CancerDetect- Oral & Throat is intended to detect molecular features associated with cancer of the oral cavity or throat.

Results should be interpreted in the context of medical history, clinical signs and symptoms. A test result of ​“NOT DETECTED” does not rule out cancer, and best practices may recommend testing again after a period of time. A test result of ​“DETECTED” requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging or biopsy) to confirm cancer. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur, as described in our scientific information.


1. Banavar G, Ogundijo O, Julian C, et al. Detecting salivary host-microbiome RNA signature for aiding diagnosis of oral and throat cancer. July 2022.
2. National Cancer Institute Surveillance, Epidemiology and End Results Program. 2021. (Cancer Stat Facts: Oral Cavity and Pharynx Cancer).
3. Peacock ZS, Pogrel MA, Schmidt BL. Exploring the Reasons for Delay in Treatment of Oral Cancer. J Am Dent Assoc. 2008;139(10):1346–52.